Rhythm Pharmaceuticals Inc [RYTM] Insider Activity: An Update for Investors

In a filing, Rhythm Pharmaceuticals Inc revealed its Chief Technical Officer Shulman Joseph unloaded Company’s shares for reported $0.42 million on Aug 21 ’25. In the deal valued at $100.07 per share,4,188 shares were sold. As a result of this transaction, Shulman Joseph now holds 8,509 shares worth roughly $0.88 million.

Then, JOSEPH SHULMAN bought 4,188 shares, generating $413,356 in total proceeds.

Before that, Smith Hunter C sold 24,611 shares. Rhythm Pharmaceuticals Inc shares valued at $2,370,832 were divested by the Chief Financial Officer at a price of $96.33 per share. As a result of the transaction, Smith Hunter C now holds 116,915 shares, worth roughly $12.06 million.

Goldman initiated its Rhythm Pharmaceuticals Inc [RYTM] rating to a Buy in a research note published on July 10, 2025; the price target was $97. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who began to cover the stock in early July with a ‘”an Outperform”‘ rating. BofA Securities also remained covering RYTM and has increased its forecast on April 07, 2025 with a “Buy” recommendation from previously “Neutral” rating.

Price Performance Review of RYTM

On Friday, Rhythm Pharmaceuticals Inc [NASDAQ:RYTM] saw its stock fall -1.04% to $103.15. Over the last five days, the stock has lost -0.12%. Rhythm Pharmaceuticals Inc shares have risen nearly 117.48% since the year began. Nevertheless, the stocks have risen 84.26% over the past one year. While a 52-week high of $104.93 was reached on 08/28/25, a 52-week low of $45.00 was recorded on 04/07/25.

Levels Of Support And Resistance For RYTM Stock

The 24-hour chart illustrates a support level at 101.73, which if violated will result in even more drops to 100.32. On the upside, there is a resistance level at 104.59. A further resistance level may holdings at 106.04.

How much short interest is there in Rhythm Pharmaceuticals Inc?

A steep rise in short interest was recorded in Rhythm Pharmaceuticals Inc stocks on 2025-08-15, dropping by -0.11 million shares to a total of 4.67 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-15 was 4.79 million shares. There was a decline of -2.46%, which implies that there is a negative sentiment for the stock.

The most recent change occurred on January 02, 2025 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $80 price target.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.